glycerol has been researched along with neuropeptide y in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (45.45) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlborg, G; Lundberg, JM; Weitzberg, E | 1 |
Ahlborg, G; Lundberg, JM; Sollevi, A; Weitzberg, E | 1 |
Beauville, M; Berlan, M; Crampes, F; Lafontan, M; Montastruc, JL; Valet, P | 1 |
Cheng, JT; Huang, JJ; Shen, CL | 1 |
Ahlborg, G; Lundberg, JM | 1 |
Aguado, M; Frühbeck, G; Martínez, JA | 1 |
Buijs, RM; Havekes, LM; Karnekamp, BN; Pijl, H; Romijn, JA; van den Hoek, AM; Voshol, PJ | 1 |
Cherrington, AD; Gustavson, SM; Moore, MC; Neal, DW; Nishizawa, M; Shiota, M | 1 |
Baker, AR; Carlsson, L; Clapham, JC; Harte, AL; Jernas, M; Kos, K; Kumar, S; McTernan, PG; O'Hare, JP | 1 |
Hainer, V; Hill, M; Nedvidkova, J; Papezova, H; Smitka, K; Vondra, K | 1 |
Guan, H; Li, R; Yang, K | 1 |
1 trial(s) available for glycerol and neuropeptide y
Article | Year |
---|---|
Exercise-induced changes in neuropeptide Y, noradrenaline and endothelin-1 levels in young people with type I diabetes.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Endothelin-1; Energy Metabolism; Exercise; Exercise Test; Glycerol; Heart Rate; Humans; Lactic Acid; Male; Neuropeptide Y; Norepinephrine; Supine Position | 1996 |
10 other study(ies) available for glycerol and neuropeptide y
Article | Year |
---|---|
Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans.
Topics: Adult; Blood Glucose; Dose-Response Relationship, Drug; Female; Glycerol; Half-Life; Heart Rate; Humans; Infusions, Intravenous; Kidney; Lactates; Lactic Acid; Male; Neuropeptide Y; Norepinephrine; Regional Blood Flow; Vasoconstriction; Viscera | 1992 |
Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man.
Topics: Adult; Blood Glucose; Exercise; Glycerol; Hemodynamics; Humans; Injections, Intravenous; Lactates; Male; Neuropeptide Y; Norepinephrine; Oxygen Consumption; Renal Circulation; Splanchnic Circulation; Vasoconstriction | 1992 |
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
Topics: Adenosine Deaminase; Adipose Tissue; Adult; Animals; Cell Membrane; Cells, Cultured; Colforsin; Dogs; Epinephrine; Fatty Acids, Nonesterified; Gastrointestinal Hormones; Glycerol; GTP-Binding Proteins; Humans; Isoproterenol; Kinetics; Lipolysis; Male; Neuropeptide Y; Peptide YY; Peptides; Pertussis Toxin; Virulence Factors, Bordetella | 1990 |
Decrease of catecholamine and neuropeptide Y-like immunoreactivity in the glycerol-induced acute renal failure of rats.
Topics: Acute Kidney Injury; Animals; Dopamine; Female; Glycerol; Male; Neuropeptide Y; Norepinephrine; Rats; Rats, Inbred Strains | 1990 |
Interactions between leptin and NPY affecting lipid mobilization in adipose tissue.
Topics: Adipocytes; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Female; Glycerol; In Vitro Techniques; Leptin; Lipolysis; Neuropeptide Y; Rats; Rats, Wistar; Recombinant Proteins | 2000 |
Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin.
Topics: Animals; Blood Glucose; Cerebral Ventricles; Fatty Acids, Nonesterified; Glucose; Glucose Clamp Technique; Glycerol; Hyperinsulinism; Infusions, Parenteral; Insulin; Kinetics; Lipoproteins, VLDL; Mice; Neuropeptide Y | 2004 |
Intraportal administration of neuropeptide Y and hepatic glucose metabolism.
Topics: Alanine; Animals; Blood Glucose; Blood Pressure; Dogs; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Heart Rate; Homeostasis; Infusions, Intravenous; Insulin; Lactic Acid; Liver; Liver Circulation; Male; Neuropeptide Y; Portal Vein; Postprandial Period; Somatostatin; Time Factors | 2008 |
DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue.
Topics: Adipocytes; Adult; Cells, Cultured; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycerol; Humans; Lipolysis; Middle Aged; Neuropeptide Y; Obesity; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Subcutaneous Fat, Abdominal | 2009 |
Acipimox during exercise points to an inhibitory feedback of GH on ghrelin secretion in bulimic and healthy women.
Topics: Adult; Body Mass Index; Bulimia Nervosa; Case-Control Studies; Exercise; Fatty Acids, Nonesterified; Feedback, Physiological; Female; Gastric Mucosa; Ghrelin; Glycerol; Human Experimentation; Human Growth Hormone; Humans; Hypolipidemic Agents; Neuropeptide Y; Pituitary Gland; Pyrazines; Stomach | 2011 |
Neuropeptide Y potentiates beta-adrenergic stimulation of lipolysis in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adenylyl Cyclases; Adipocytes; Adrenergic beta-Agonists; Animals; Carrier Proteins; Colforsin; Energy Metabolism; Enzyme Activators; Fatty Acid Synthases; Gene Expression; Glycerol; Isoproterenol; Lipase; Lipolysis; Mice; Neuropeptide Y; Perilipin-1; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Second Messenger Systems; Stearoyl-CoA Desaturase; Sterol Esterase | 2012 |